Synergistic Use of Geniposide and Ginsenoside Rg1 Balance Microglial TNF- and TGF-1 following Oxygen-Glucose Deprivation In Vitro: A Genome-Wide Survey

Figure 4

Results of KEGG pathway analysis. (a) Venn diagram of the significant pathways distribution of the 3 treatment groups. (b) Seven overlapping pathways all activated in the 3 treatment groups. G versus M, pathways from differential expressed genes in geniposide-treated group compared with model group; R versus M, pathways from differential expressed genes in ginsenoside-Rg1-treated group compared with model group; G+R versus M, pathways from differential expressed genes in combination-treated group compared with model group.

(a)

(b)